FEMALAC®
Two products, one shared platform
APOGEPHA has reorganized the digital presence of its products FEMALAC® D-Mannose + Lactobacilli and UROL®FLUX Durchspül-Therapie. Previously separate content was consolidated into a single shared website. The goal was to present both products clearly while enabling efficient editorial management. The result is a modern, accessible TYPO3 website that provides patients with clear and understandable information on one central platform.
Rebranding as part of the product transition
As of September 1, 2025, FEMALAC® was reclassified from a medical device to a dietary supplement. The reason was regulatory changes at the EU level that called its long-term marketability as a medical device into question. At the same time, the product received an optimized formulation.
This transition provided the opportunity to fundamentally revise the existing product website. The goal was to make the new product positioning visible while consolidating the content for the over-the-counter medicinal product UROL® FLUX Durchspül-Therapie into a shared platform. The standalone domain urolflux.de was to be discontinued as part of this process.
- Industry
- Pharmaceutical Industry
- Technology
- TYPO3 Content Management System
- Services
- Corporate Website
Our Implementation
Step by step to the new platform
Together with APOGEPHA and the partners xeomed and Healthy Brands, the project was implemented in several phases — from concept and design to technical implementation and content creation. Technically, the new website was integrated into APOGEPHA’s existing TYPO3 system. Existing page types, navigation structures, and modules were reused and visually adapted for FEMALAC® D-Mannose + Lactobacilli and UROL® FLUX Durchspül-Therapie. In addition, we developed custom components such as a new hero stage and flexible teaser elements tailored specifically to the needs of product communication. Particular attention was given to the new navigation structure, which provides equal visibility for both products and enables intuitive orientation.
Design
Two brands, one look
The design builds on established visual elements from the APOGEPHA brand environment and was translated into the corporate design of the FEMALAC® and UROL® FLUX brands in close coordination. The goal was to create a consistent brand presence that feels familiar while clearly emphasizing the individuality of each product. A dual color concept visually separates the content of FEMALAC® (pink) and UROL® FLUX (blue). The website is fully responsive and enhanced with subtle animations.
Result
Central platform, clear positioning
With femalac.de, APOGEPHA now has a modern product website where FEMALAC® and UROL® FLUX are clearly distinguished in terms of content and presented in a structured, transparent way. Website users benefit from a shared digital environment that provides transparent and easy-to-understand information on areas of application, composition, and product characteristics, while offering guidance and confidence in product use. Implemented as a multidomain setup, both websites are managed within a single TYPO3 instance. Editorial maintenance, security updates, and system upgrades are therefore handled centrally in one shared system environment instead of across two separate systems.
Axel Schreinemachers
Head of OTC, APOGEPHA Arzneimittel GmbH
That's what our customer says
The collaboration between all parties involved was consistently characterized by professionalism, openness, and well-coordinated cooperation on equal footing, creating particular added value. Our sincere thanks for the consistently straightforward, constructive, and creative collaboration throughout the entire project.